Volume : 13, Issue : 03, March – 2026

Title:

PHARMACOGNOSY IN THE ERA OF NANOTECHNOLOGY: HERBAL-BASED NANOFORMULATIONS AND THEIR THERAPEUTIC APPLICATIONS

Authors :

Karche Pranjali Vishwambhar*, Kashid Rohan Madhukar, Swapnali Yuvraj Kengar, Vagare Dnyaneshwari Balasaheb, Dr. Rahul Ishwara Jadhav

Abstract :

Pharmacognosy, the science of natural product-based drug discovery, has evolved significantly with the integration of nanotechnology. Herbal medicines, though widely accepted due to their safety and therapeutic efficacy, suffer from limitations such as poor solubility, low bioavailability, instability, and rapid degradation. Nanotechnology-based drug delivery systems offer promising solutions to these challenges by improving drug solubility, stability, and targeted delivery. Herbal nanoformulations such as liposomes, polymeric nanoparticles, nanoemulsions, solid lipid nanoparticles (SLNs), and nanostructured lipid carriers (NLCs) have demonstrated enhanced pharmacokinetic and pharmacodynamic properties. These systems enable controlled drug release, reduce toxicity, and improve therapeutic outcomes. This review highlights the principles, types, mechanisms, advantages, applications, challenges, and future prospects of herbal nanoformulations in pharmaceutical sciences.
Keywords: Pharmacognosy, Nanotechnology, Herbal nanoformulations, Drug delivery, Phytoconstituents, Bioavailability

Cite This Article:

Please cite this article in press Rahul Ishwara Jadhav et al., Pharmacognosy In The Era Of Nanotechnology: Herbal-Based Nanoformulations And Their Therapeutic Applications., Indo Am. J. P. Sci, 2026; 13(03).

REFERENCES:

1. Patel A et al. J Control Release. 2020.
2. Torchilin VP. Nat Rev Drug Discov. 2014.
3. Allen TM, Cullis PR. Adv Drug Deliv Rev. 2013.
4. Zhang L et al. Clin Pharmacol Ther. 2008.
5. Danaei M et al. Pharmaceutics. 2018.
6. Couvreur P. Adv Drug Deliv Rev. 2013.
7. Parveen S et al. Nanomedicine. 2012.
8. Muthu MS et al. Nanomedicine. 2011.
9. Wang AZ et al. Nat Rev Drug Discov. 2012.
10. Duncan R. Nat Rev Cancer. 2006.
11. Ferrari M. Nat Rev Cancer. 2005.
12. Langer R. Nature. 1998.
13. Kreuter J. J Control Release. 2001.
14. Alexis F et al. Mol Pharm. 2008.
15. Bae YH, Park K. J Control Release. 2011.
16. Brigger I et al. Adv Drug Deliv Rev. 2002.
17. Koo OM et al. Int J Nanomedicine. 2005.
18. Peer D et al. Nat Nanotechnol. 2007.
19. Blanco E et al. Nat Biotechnol. 2015.
20. Kalepu S et al. Acta Pharm Sin B. 2015.
21. Amidon GL et al. Pharm Res. 1995.
22. Lipinski CA. Adv Drug Deliv Rev. 2000.
23. Dressman JB. Eur J Pharm Sci. 2000.
24. Kreuter J. Nanoparticles in drug delivery. J Control Release. 2001.